SCHEMBL9768036

SCHEMBL9768036

O=C(CNCCc1ccccc1)c1ccc(O)c(O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.55
ADRB2 P07550 1/20 0.55
ADORA3 P0DMS8 1/20 0.55
CHRM1 P11229 1/20 0.55
ADRA2B P18089 1/20 0.55
ADRA2C P18825 1/20 0.55
DRD1 P21728 1/20 0.55
SLC6A2 P23975 1/20 0.55
SLC6A4 P31645 1/20 0.55
ADRA1A P35348 1/20 0.55
HRH1 P35367 1/20 0.55
DRD3 P35462 1/20 0.55
OPRK1 P41145 1/20 0.55
SLC6A3 Q01959 1/20 0.55
PDE4D Q08499 1/20 0.55
KCNH2 Q12809 1/20 0.55
HRH3 Q9Y5N1 1/20 0.55
TRPV1 Q8NER1 1/20 0.49
GAA P10253 4/20 0.48
MEN1 O00255 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10071961 0.92 ADRB2 (0.52) PTGS2ADRB2ADORA3CHRM1ADRA2B
SCHEMBL11271218 0.87 HDAC1 (0.45) PTGS2ADRB2ADORA3CHRM1ADRA2B
Hydrochloric Acid SCHEMBL11277285 0.86 HDAC1 (0.44) PTGS2ADRB2ADORA3CHRM1ADRA2B
SCHEMBL9768039 0.85 GAA (0.61) PTGS2ADRB2ADORA3CHRM1ADRA2B
Formic Acid SCHEMBL30892158 0.81 MMP1 (0.46) PTGS2GAAMEN1KMT2AMMP1
Acetic Acid SCHEMBL22551315 0.81 ALPL (0.46) PTGS2GAAMEN1KMT2AMMP1
Formic Acid SCHEMBL22551318 0.81 MMP1 (0.46) PTGS2GAAMEN1KMT2AMMP1
SCHEMBL4983444 0.80 DPP4 (0.64) PTGS2ADRB2ADORA3ADRA2BADRA2C
SCHEMBL2291802 0.79 NPC1 (0.63) KCNH2KMT2AHDAC1HDAC2TAAR1
SCHEMBL2293951 0.79 MGLL (0.55) GAAKMT2AHDAC1HDAC2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116162036-A Preparation method of epinephrine impurity 绪必迪药业(沧州)有限公司 2023-05-26 CN disclosed
US-5047592-A Selective hydrogenolysis process ETHYL CORPORATION (US) 1991-09-10 US disclosed
EP-0108822-B1 ANTIGLAUCOMA COMPOUNDS USV PHARMACEUTICAL CORPORATION (US) 1986-08-13 EP disclosed